Navigation Links
Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data
Date:5/18/2009

eSeal(R) Hemostasis Patch.

About MEDRAD, INC.

MEDRAD, INC. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. MEDRAD's total 2008 revenues were over $600 million. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.

Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can b
'/>"/>

SOURCE MEDRAD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CDC Analysis Finds Unique Social and Behavior Intervention Helps Reduce MRSA Rates Up to 62% in Study Hospitals
2. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. Unique Hearing Aid Receives Patent Protection
5. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
6. ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
7. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
8. Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient
9. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
10. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
11. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015  Relmada Therapeutics, Inc. (OTCQB: ... the treatment of chronic pain, today announced the ... advisory roles. The panel of experts will provide ... efforts to advance the company pipeline of novel ... expertise in a range of areas including opioid ...
(Date:3/5/2015)... 2015 LUNGevity Foundation, the nation,s leading ... Administration,s (FDA) approval of Bristol Myers Squibb,s new ... treatments add another critical new treatment option to ... a patient,s own immune system to fight cancerous ... for patients with squamous cell lung cancer, a ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Japan Pharma Outlook 2015: Year to Watch ... Initiatives" report to their offering. ... from April -2014 (Annexure 1) is a ... - whether generic or innovator. The most of the ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
... 2011 Reportlinker.com announces that a new ... catalogue: Pharmaceutical Key Trends ... the pharmaceutical industry ... A number of factors have ...
... Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced ... Administration,s (the "FDA") Division of Oncology Drug Products (the ... New Drug Application (the "NDA") for pixantrone for relapsed ... for accelerated approval based on the PIX301 study results. ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry 2Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry 3Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry 4Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval 2Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval 3Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval 4
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 SuperCloset has ... SuperPro! The series aims to teach viewers everything they ... with hydroponics. Grow Like a SuperPro takes you from seed ... From how to clone, to how to prune Grow Like ... They are offering the whole series for download for a ...
(Date:3/5/2015)... MALVERN, PA (PRWEB) March 05, 2015 ... a leader in healthcare communications and education, announced ... Symposium (AMP), the nation’s only medical conference ... critical limb ischemia and lower limb amputation due ... HMP’s growing family of innovative, evidence-based publications and ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Taking ... in Fort Worth, Texas April 9-11th is IDRevolution ... company providing personalized nutrition. IDLife offers a ... IDNutrition. This customized approach to vitamin supplementation ... begins with a free HIPAA compliant online assessment ...
(Date:3/5/2015)... March 05, 2015 INTEGRATED Healthcare ... organizations to participate in its 2015 Children’s Hospitals ... executive and director-level positions, and the survey results ... year’s report featured data on 60 executive and ... healthcare organizations and 7 subsidiary children’s hospitals. Additionally, ...
(Date:3/5/2015)... 05, 2015 Nutrition Leaders, a premier ... pleased to offer reformulated Millennium 500 Creatine to its ... is a German grade creatine supplement that has been ... recovery, and aid with overall strength gains in users. ... as a reserve energy source in the body and ...
Breaking Medicine News(10 mins):Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2
... Myeloma ( www.ManagingMyeloma.com ), an accredited ... for fellows in oncology to win a scholarship to ... Meeting in New Orleans, Louisiana. The scholarship includes registration ... for meals. , During the conference, the ...
... ... designed to inform our users that the life saving medications they or their loved ... ... -- Recently, WarrantyElephant met with the founder of AllergySense.com, Rhonda Lewis, a WarrantyElephant user, ...
... ... knee amputee, and world record holder in over 10 events in running and triathlon set ... Spirit of the Prairie 100 mile Trail Run in Cassoday, Kansas, Ms. Palmerio-Winters not only ... and finished in 8th place overall. , , ...
... ZURICH, Switzerland, October 15 ... 17 and 18 October 2009. Medical staff, but,particularly administrators ... exceptional introduction to the latest achievements,in football medicine and ... all levels of play. , ...
... Calif., Oct. 14 Beckman Coulter, Inc. (NYSE: BEC ... Thursday, October 29, 2009, at 5:00 p.m. ET to discuss ... released after the market closes. , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ... 516-3365 or (706) 679-3246 and asking for the Beckman Coulter ...
... , TACOMA, Wash., Oct. 14 Spectrum Pension Consultants, a ... to announce that the 2009 Spectrum Open raised over $100,000, ... oncology unit at St. Joseph,s Hospital. , "This event was ... a participation and fundraising perspective. It was incredible to watch ...
Cached Medicine News:Health News:Managing Myeloma Website Announces Fellow Scholarship Program to Attend and Report on Annual American Society of Hematology in New Orleans 2Health News:WarrantyElephant Launches "MediElephant" a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis, Founder of AllergySense 2Health News:First Female Amputee To Run a 100 Mile Trail Run Wins the Race 2Health News:FIFA Medical Conference, 17 and 18 October 2009 in Zurich 2Health News:FIFA Medical Conference, 17 and 18 October 2009 in Zurich 3Health News:4th Annual Spectrum Open: A Big Success 2
For use with Crawford Intubation Systems....
For canalicular laceration involving external 2/3 of one canaliculus. Medical grade silicone. Box of 3, sterile. Note: For safe and proper insertion of the punctum plug above, we recommend the use of...
... system uses prolene as thread-guide reducing time ... hollow Ritleng Probe is inserted into the ... is fed through it. The probe is ... pull the silicone tubing in place. Newly ...
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Medicine Products: